XiaoweiXuMD

Dermatopathology, Anatomic Pathology, Clinical Pathology

Associate Professor, Pathology & Laboratory Medicine, Perelman School of Medicine

Dr. Xu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Dermatopathology, 2001 - 2002
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1997 - 2001
Shandong Medical UniversityClass of 1992

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

PubMed

16 citations
Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms.
Sarah Benton, Jeffrey Zhao, Bin Zhang, Armita Bahrami, Raymond L. Barnhill
The American Journal of Surgical Pathology. 2021-12-01
1316 citations
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF -mutant melanoma
Gideon Bollag, Peter Hirth, James Tsai, Jiazhong Zhang, Prabha N. Ibrahim
Nature. 2010-09-30
979 citations
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
Jessie Villanueva, Adina Vultur, John T. Lee, Rajasekharan Somasundaram, Mizuho Fukunaga-Kalabis
Cancer Cell. 2010-12-14

Journal Articles

Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 Response
Xiaowei Xu, Haidong Dong, Tara C Mitchell, Lynn M Schuchter, Alexander C Huang, Suzanne McGettigan, Wei Xu, Giorgos C Karakousis, Xiaoming Liu, Gordon Mills, Nature
Pathological Assessment of Resection Specimens After Neoadjuvant Therapy for Metastatic Melanoma
M T Tetzlaff, J E Gershenwald, X Xu, V G Prieto, T Mitchell, M A Davies, J M Taube, Annals of Oncology
A Designer Cross-Reactive DNA Immunotherapeutic Vaccine That Targets Multiple MAGE-A Family Members Simultaneously for Cancer Therapy
Xiaoming Liu, Xiaowei Xu, Clinical Cancer Research

Penn Medicine and Wistar Secure $11.7 Million SPORE Grant for Three Melanoma Research ProjectsSeptember 22nd, 2021
Young People Fear Poor Mental Health Will Affect Post-Covid Job ProspectsJuly 4th, 2021
Adoptive T Cell Immunotherapy for Medullary Thyroid Carcinoma Targeting GDNF Family Receptor Alpha 4January 26th, 2021
Join now to see all